Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil.

Literature DB >> 22895071

Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil.

Dennis R Harris¹, Alexandra Mims, Fred Bunz.

Abstract

The X-linked deubiquitinase USP9X affects the stability and activity of numerous regulatory proteins that influence cell survival. Recent studies suggest that decreased USP9X expression can confer a selective advantage onto developing cancer cells and thereby promotes disease progression. To examine the effect of USP9X on the cellular responses to anticancer therapies, we derived cancer cell lines in which the USP9X locus was disrupted by homologous recombination. The resulting USP9X-deficient cancer cells exhibited increased activation of apoptotic pathways and markedly decreased clonogenic survival in response to 5-fluorouracil, a chemotherapeutic drug that is widely used for treatment of gastrointestinal malignancies. These unexpected results suggest that cancers with low USP9X expression might be specifically sensitized to some conventional therapeutic agents.

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 2012 PMID： 22895071 PMCID： PMC3493440 DOI： 10.4161/cbt.21792

Source DB: PubMed Journal: Cancer Biol Ther ISSN： 1538-4047 Impact factor: 4.742

22 in total

1. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors: Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal: N Engl J Med Date: 2011-05-12 Impact factor: 91.245

2. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells.

Authors: P M Hwang; F Bunz; J Yu; C Rago; T A Chan; M P Murphy; G F Kelso; R A Smith; K W Kinzler; B Vogelstein
Journal: Nat Med Date: 2001-10 Impact factor: 53.440

3. Zymophagy, a novel selective autophagy pathway mediated by VMP1-USP9x-p62, prevents pancreatic cell death.

Authors: Daniel Grasso; Alejandro Ropolo; Andrea Lo Ré; Verónica Boggio; María I Molejón; Juan L Iovanna; Claudio D Gonzalez; Raúl Urrutia; María I Vaccaro
Journal: J Biol Chem Date: 2010-12-20 Impact factor: 5.157

4. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.

Authors: Martin Schwickart; Xiaodong Huang; Jennie R Lill; Jinfeng Liu; Ronald Ferrando; Dorothy M French; Heather Maecker; Karen O'Rourke; Fernando Bazan; Jeffrey Eastham-Anderson; Peng Yue; David Dornan; David C S Huang; Vishva M Dixit
Journal: Nature Date: 2009-12-20 Impact factor: 49.962

Review 5. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death.

Authors: Domagoj Vucic; Vishva M Dixit; Ingrid E Wertz
Journal: Nat Rev Mol Cell Biol Date: 2011-06-23 Impact factor: 94.444

6. Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors.

Authors: Jung-Sik Kim; Heather Crooks; Aaron Foxworth; Todd Waldman
Journal: Mol Cancer Ther Date: 2002-12 Impact factor: 6.261

7. Inactivation of hCDC4 can cause chromosomal instability.

Authors: Harith Rajagopalan; Prasad V Jallepalli; Carlo Rago; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer
Journal: Nature Date: 2004-03-04 Impact factor: 49.962

8. P21 gene knock down does not identify genetic effectors seen with gene knock out.

Authors: Bedri Karakas; Ashani T Weeraratna; Abde M Abukhdeir; Hiroyuki Konishi; John P Gustin; Michele I Vitolo; Kurtis E Bachman; Ben Ho Park
Journal: Cancer Biol Ther Date: 2007-07 Impact factor: 4.742

9. ATR mediates cisplatin resistance in a p53 genotype-specific manner.

Authors: N Sangster-Guity; B H Conrad; N Papadopoulos; F Bunz
Journal: Oncogene Date: 2011-01-24 Impact factor: 9.867

10. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.

Authors: Pedro A Pérez-Mancera; Alistair G Rust; Louise van der Weyden; Glen Kristiansen; Allen Li; Aaron L Sarver; Kevin A T Silverstein; Robert Grützmann; Daniela Aust; Petra Rümmele; Thomas Knösel; Colin Herd; Derek L Stemple; Ross Kettleborough; Jacqueline A Brosnan; Ang Li; Richard Morgan; Spencer Knight; Jun Yu; Shane Stegeman; Lara S Collier; Jelle J ten Hoeve; Jeroen de Ridder; Alison P Klein; Michael Goggins; Ralph H Hruban; David K Chang; Andrew V Biankin; Sean M Grimmond; Lodewyk F A Wessels; Stephen A Wood; Christine A Iacobuzio-Donahue; Christian Pilarsky; David A Largaespada; David J Adams; David A Tuveson
Journal: Nature Date: 2012-04-29 Impact factor: 49.962

19 in total

1. Deubiquitinase inhibition by WP1130 leads to ULK1 aggregation and blockade of autophagy.

Authors: Stefan Drießen; Niklas Berleth; Olena Friesen; Antje S Löffler; Philip Böhler; Nora Hieke; Fabian Stuhldreier; Christoph Peter; Kay O Schink; Sebastian W Schultz; Harald Stenmark; Petter Holland; Anne Simonsen; Sebastian Wesselborg; Björn Stork
Journal: Autophagy Date: 2015 Impact factor: 16.016

2. USP9X, a Putative Tumor Suppressor Gene, Exhibits Frameshift Mutations in Colorectal Cancers.

Authors: Yun Sol Jo; Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee
Journal: Pathol Oncol Res Date: 2016-10-21 Impact factor: 3.201

3. Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patients.

Authors: Wei Liu; Yanmiao Huo; Jianyu Yang; Xueliang Fu; Minwei Yang; Lingye Tao; Dejun Liu; Junfeng Zhang; Rong Hua; Yongwei Sun
Journal: Oncol Lett Date: 2018-04-10 Impact factor: 2.967

4. Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma.

Authors: Jesse L Cox; Phillip J Wilder; Erin L Wuebben; Michel M Ouellette; Michael A Hollingsworth; Angie Rizzino
Journal: Cancer Biol Ther Date: 2014-05-19 Impact factor: 4.742

5. Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I).

Authors: Zhenghong Peng; David S Maxwell; Duoli Sun; Basvoju A Bhanu Prasad; Paul T Schuber; Ashutosh Pal; Yunming Ying; Dongmei Han; Liwei Gao; Shimei Wang; Alexander Levitzki; Vaibhav Kapuria; Moshe Talpaz; Matthew Young; Hollis D Showalter; Nicholas J Donato; William G Bornmann
Journal: Bioorg Med Chem Date: 2014-01-03 Impact factor: 3.641

6. Deubiquitylating enzyme, USP9X, regulates proliferation of cells of head and neck cancer lines.

Authors: D M Nanayakkara; M N Nguyen; S A Wood
Journal: Cell Prolif Date: 2016-07-04 Impact factor: 6.831

7. Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer.

Authors: J Izrailit; A Jaiswal; W Zheng; M F Moran; M Reedijk
Journal: Oncogene Date: 2016-09-05 Impact factor: 9.867

8. miR-542-3p inhibits colorectal cancer cell proliferation, migration and invasion by targeting OTUB1.

Authors: Long Yuan; Peng Yuan; Huijuan Yuan; Zhenlei Wang; Zengci Run; Guanglong Chen; Peng Zhao; Benling Xu
Journal: Am J Cancer Res Date: 2017-01-01 Impact factor: 6.166

9. RANBP2 and USP9x regulate nuclear import of adenovirus minor coat protein IIIa.

Authors: Ashrafali M Ismail; Amrita Saha; Ji S Lee; David F Painter; Yinghua Chen; Gurdeep Singh; Gabriela N Condezo; James Chodosh; Carmen San Martín; Jaya Rajaiya
Journal: PLoS Pathog Date: 2022-06-16 Impact factor: 7.464

10. Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis.

Authors: Yong Wu; Xiaoting Yu; Xianghua Yi; Ke Wu; Sami Dwabe; Mohammad Atefi; Yahya Elshimali; Kevin T Kemp; Kruttika Bhat; Jesse Haro; Marianna Sarkissyan; Jaydutt V Vadgama
Journal: Cancer Res Date: 2017-01-23 Impact factor: 13.312